Lymphomatous Involvement of Non-Cutaneous Extranodal Site

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB05220Alisertib1Completed1
DB01254Dasatinib1Completed1
DB00480Lenalidomide1Completed1
DB02546Vorinostat1Completed1
DB06769Bendamustine1 / 2Completed1
DB00073Rituximab1 / 2Completed1
DB07232Veliparib1 / 2Completed1